Purple Biotech's total assets for Q3 2025 were $39.06M, an increase of 13.62% from the previous quarter. PPBT total liabilities were $6.25M for the fiscal quarter, a 168.18% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.